The Leadership Team at IFM Therapeutics is dedicated to guiding the company’s strategic vision and fostering innovation in the development of therapies for inflammatory disorders and cancer. Comprising scientific founders and executive leaders, this team drives research initiatives, oversees clinical development, and ensures alignment with the company's mission to leverage innate immunity for transformative medicine. Their collective expertise shapes the organization’s goals and enhances its ability to deliver impactful treatments to patients.
Andrea Ablasser
Scientific Founder
Anthony Opipari
Scientific Founder
Dennis Dean
Chief Development Officer
Ed Olhava
SVP of Preclinical Development
Eicke Latz
Scientific Founder
Gary D. Glick
Founder & Executive Chairman, ...
H. Martin Seidel
Chief Executive Officer
Luigi Franchi
Scientific Founder
Matthias Geyer
Scientific Founder
William R. Roush
EVP of Chemistry
View all